GMC to convene meeting for prescribing debateBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7574.918-b (Published 26 October 2006) Cite this as: BMJ 2006;333:918
EDITOR—I am pleased that Aronson et al recognise the need for evidence to inform the debate over prescribing, and I note that they have broadened their interest to include postgraduate education.1 The General Medical Council's education committee already has information relating to the undergraduate phase and is collecting more through its ongoing research into how well its requirements, described in Tomorrow's Doctors,2 prepare new graduates for the foundation programme and beyond.
However, there is a paucity of evidence relating to factors that could improve the quality of prescribing in later stages of a doctor's training and career. There is a growing risk that this debate will escalate in the wider media, where the underlying issues are not widely understood, with resulting alarm to patients and the public about their safety. It is essential that this perception does not become entrenched. The GMC therefore strongly supports the value of acquiring such evidence and will convene a meeting of interested parties to take this important matter forward.
Competing interests None declared.